排泄与Helicobacter pylori的抗性基因突变之间的交叉关系
Xiaoling Gong1,2,3,4, Youhua Wang1,2,3,4, Ying An1,2,3,4,5
1Department of Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Gut microbes
|July 25, 2024
概括
在Helicobacter pylori中排泄影响抗生素耐药性. 基因突变会影响活动,阻断排泄可以延迟耐药性,并逆转一些药物耐药性表型.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 抗生素耐药性是一个日益增长的全球健康威胁.
- 溢出是对细菌多药性耐药性的重要贡献者.
- 了解Helicobacter pylori的排泄功能对于开发新疗法至关重要.
研究的目的:
- 为了研究排泄基因表达与Helicobacter pylori抗生素耐药性基因突变之间的关系.
- 评估排泄基因淘汰对抗生素耐药性的发展和逆转的影响.
主要方法:
- 在临床Helicobacter pylori菌株中分析排泄基因表达 (hefA, hefD).
- 在敏感菌株中诱导抗生素耐药性,以监测基因表达和突变.
- 构建候选突变菌株和排泄淘汰菌株.
- 评估 knockout 菌株中的表型耐药性和耐药性基因突变.
主要成果:
- 在多药耐药菌株中显著更高的hefa和hefD表达.
- 在抗生素诱导的耐药性发展过程中,可变的排泄基因表达.
- 在23SrRNA,gyrA和rdxA中的特定突变与改变的hefa表达相关.
- 一些菌株的hEFA耐药性基因突变延迟并逆转了克拉里胺/美特罗尼达耐药性表型.
结论:
- 抗生素耐药性基因突变对Helicobacter pylori的排泄基因表达有差异性影响.
- 准排泄可以延迟抗生素耐药性的出现.
- 排泄抑制显示出逆转现有的抗生素耐药性表型的潜力.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
343
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
343
00:57Antibiotic Selection
52.9K
Overview
52.9K
01:36Mismatch Repair
40.0K
Overview
40.0K
01:06Carrier-Mediated Transport
322
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
322
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:46Genome Copying Errors
4.2K
DNA replication is a well-evolved process that copies millions of base pairs with high fidelity during each cell division. Occasionally a wrong base or a long stretch of wrong bases may get added to the daughter strands. If the errors are left unchecked, cells might accumulate several mutations that might endanger their survival. Therefore, the copying errors are checked and repaired at three levels.
4.2K